Suivre
Aude A. Ferran
Titre
Citée par
Citée par
Année
Species differences in pharmacokinetics and pharmacodynamics
PL Toutain, A Ferran, A Bousquet-Mélou
Comparative and Veterinary Pharmacology, 19-48, 2010
2782010
En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
PL Toutain, A Bousquet-Mélou, P Damborg, AA Ferran, D Mevius, ...
Frontiers in microbiology 8, 2344, 2017
1442017
Veterinary Medicine Needs New Green Antimicrobial Drugs
PL Toutain, AA Ferran, A Bousquet-Melou, L Pelligand, P Lees
Frontiers in Microbiology 7, 1196, 2016
702016
Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection
AA Ferran, PL Toutain, A Bousquet-Mélou
Veterinary microbiology 148 (2), 292-297, 2011
692011
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial …
AA Ferran, AS Kesteman, PL Toutain, A Bousquet-Mélou
Antimicrobial agents and chemotherapy 53 (8), 3384-3390, 2009
662009
Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model
AS Kesteman, AA Ferran, A Perrin-Guyomard, M Laurentie, P Sanders, ...
Antimicrobial agents and chemotherapy 53 (11), 4740-4748, 2009
612009
Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin
A Ferran, V Dupouy, PL Toutain, A Bousquet-Mélou
Antimicrobial agents and chemotherapy 51 (11), 4163-4166, 2007
602007
The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal
PL Toutain, L Pelligand, P Lees, A Bousquet‐Mélou, AA Ferran, ...
Journal of Veterinary Pharmacology and Therapeutics 44 (2), 172-200, 2021
552021
Low or High Doses of Cefquinome Targeting Low or High Bacterial Inocula Cure Klebsiella pneumoniae Lung Infections but Differentially Impact the Levels of Antibiotic Resistance …
MV Vasseur, M Laurentie, JG Rolland, A Perrin-Guyomard, J Henri, ...
Antimicrobial agents and chemotherapy 58 (3), 1744-1748, 2014
402014
Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
D Concordet, P Gandia, JL Montastruc, A Bousquet-Mélou, P Lees, ...
Clinical pharmacokinetics, 1-7, 2019
392019
In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
EA Lallemand, MZ Lacroix, PL Toutain, S Boullier, AA Ferran, ...
Frontiers in Microbiology 7, 2016
382016
Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica
G Lhermie, AA Ferran, S Assié, H Cassard, F El Garch, M Schneider, ...
Frontiers in Microbiology 7, 2016
382016
Use of Monte Carlo simulation to determine pharmacodynamic cutoffs of amoxicillin to establish a breakpoint for antimicrobial susceptibility testing in pigs
JF Rey, CM Laffont, S Croubels, P De Backer, C Zemirline, E Bousquet, ...
American Journal of Veterinary Research 75 (2), 124-131, 2014
352014
Pharmacokinetic/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: Comparison of bactericidal activity at …
AA Ferran, D Bibbal, T Pellet, M Laurentie, M Gicquel-Bruneau, ...
International journal of antimicrobial agents 42 (5), 429-435, 2013
352013
Differential activity of the combination of vancomycin and amikacin on planktonic versus biofilm-growing Staphylococcus aureus in a Hollow Fiber Infection Model
DC Broussou, MZ Lacroix, PL TOUTAIN, F WOEHRLE, F EL GARCH, ...
Frontiers in Microbiology 9, 572, 2018
322018
Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate
JJ Liu, JY Madec, A Bousquet-Mélou, M Haenni, AA Ferran
Scientific reports 11 (1), 1-12, 2021
232021
Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
DC Broussou, PL Toutain, F Woehrlé, F El Garch, A Bousquet-Melou, ...
PloS one 14 (1), e0211214, 2019
212019
Comparison of the in vitro activity of five antimicrobial drugs on Staphylococcus pseudintermedius and Staphylococcus aureus biofilms
AA Ferran, JJ LIU, A Bousquet-Mélou, PL TOUTAIN
Frontiers in Microbiology 7, 1187, 2016
202016
Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 1: Methodology, general data gaps and uncertainties
EFSA Panel on Biological Hazards (BIOHAZ), K Koutsoumanis, A Allende, ...
EFSA Journal 19 (10), e06852, 2021
142021
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
MV Vasseur, MZ Lacroix, PL Toutain, A Bousquet-Melou, AA Ferran
PloS one 12 (8), e0182863, 2017
142017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20